| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/21/2013 | WO2013024174A1 Dha triglyceride, dha free fatty acid, and dha ethyl ester emulsions, and methods of treating spinal cord injury |
| 02/21/2013 | WO2013024067A1 Use of antioxidants for improving animal health |
| 02/21/2013 | US20130046018 Dietary supplements containing terpenoid acids of maslinic acid or oleanolic acid and process for enhancing muscle mass in mammals |
| 02/21/2013 | US20130045992 Compositions and Methods for Enhancing Proteasome Activity |
| 02/21/2013 | US20130045972 Glucocorticoid receptor antagonists |
| 02/21/2013 | US20130045971 Induced hypothermia |
| 02/21/2013 | US20130045952 ABA Receptor Agonists for Increased Plant Stress Resistance |
| 02/21/2013 | US20130045950 Phosphonate Compounds |
| 02/21/2013 | US20130045924 Methods of reducing hypoxic stress in a mammal by administering soluble p-selectin |
| 02/21/2013 | US20130045520 Double-stranded oligonucleotides |
| 02/21/2013 | US20130045180 Vaccines, immunotherapeutics and methods for using the same |
| 02/21/2013 | CA2844794A1 Heterocyclic derivative and pharmaceutical |
| 02/21/2013 | CA2844750A1 Method for preparing nucleic acid aptamer |
| 02/21/2013 | CA2842887A1 Mphosph1 peptides and vaccines including the same |
| 02/20/2013 | EP2559705A2 Anti-activin a antibodies and uses thereof |
| 02/20/2013 | EP2559693A1 Polycyclic compound |
| 02/20/2013 | EP2559437A1 Intestinal protectant |
| 02/20/2013 | EP2558083A1 Methods for providing enhanced resveratrol activity using 4-acetoxy-resveratrol |
| 02/20/2013 | CN102939284A Agent for treating hcv infection |
| 02/20/2013 | CN102939083A Laminin-332 production accelerating composition |
| 02/20/2013 | CN102936212A Guanylhydrazone compounds, compositions, methods of making and using |
| 02/20/2013 | CN102935102A Method for simultaneously producing honeysuckle flower distillate and various active substances |
| 02/20/2013 | CN102935062A Polymeric micelle composition loaded with epothilone compound or derivatives thereof, freezed-drying preparation, and preparation and application thereof |
| 02/20/2013 | CN101678077B Novel antiphlogistic-analgesic agent |
| 02/20/2013 | CN101468196B Method for preparing tetrandra and astragalus decoction preparation |
| 02/19/2013 | USRE44017 N-acetyl aldosamines, N-acetylamino acids and related N-acetyl compounds and their topical use |
| 02/19/2013 | US8378099 Boronic ester and acid compounds, synthesis and uses |
| 02/19/2013 | US8377950 Crystalline form of 5-[4-[[3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl]methoxy]benzyl]thiazolidine-2,4-dione potassium salt |
| 02/19/2013 | US8377936 Nicotinic receptor agonists for the treatment of inflammatory diseases |
| 02/19/2013 | US8377931 Benzoxazine derivatives and uses thereof |
| 02/19/2013 | US8377893 Highly purified antiendotoxin compound |
| 02/19/2013 | US8377865 Growth hormone releasing peptides |
| 02/19/2013 | US8377654 Stable galenic freeze-dried pharmaceutical preparation of recombinant carbohydrate-binding polypeptides |
| 02/19/2013 | US8377645 Unc-33 like phosphoprotein (ULIP) polypeptide for generating antibodies for use in diagnosis, preventnion and treatment of neurodegenerative and neoplastic disorders |
| 02/19/2013 | US8377483 Bioactivation of iron salt, especially an ferric ferrous salt, by adding a magnesium salt (MgCl2); useful as a medicine to treat diseases such as diabetes, freshness preservative agent, and animal and plant growth promoter |
| 02/19/2013 | US8377481 Apparatus and method to generate a mixture of hydrogen peroxide gas and a carrier gas |
| 02/19/2013 | US8377428 Low salt forms of polyallylamine |
| 02/19/2013 | US8377420 Injectable void filler for soft tissue augmentation |
| 02/19/2013 | CA2547820C (s)-2-n-propylamino-5-hydroxytetralin as a d3 agonist |
| 02/19/2013 | CA2486187C Kinase inhibitors |
| 02/19/2013 | CA2467930C Treatment of pml targeting jc virus agno |
| 02/19/2013 | CA2448382C Use of hepcidin as a regulator of iron homeostasis |
| 02/14/2013 | WO2013022092A1 Heptamer-type small guide nucleic acid capable of inducing apoptosis of human hematologic cancer cells |
| 02/14/2013 | WO2013022059A1 Pharmaceutical composition containing diamine derivative |
| 02/14/2013 | WO2013021302A1 Anti-oxidant herbal composition |
| 02/14/2013 | WO2013020600A1 Pharmaceutical composition comprising a drug containing at least one toxicophore function and n-acetyl-l-cysteine |
| 02/14/2013 | WO2013020440A1 Amide derivate, and preparation method therefor, pharmaceutical composition and use thereof |
| 02/14/2013 | WO2013020371A1 Pim kinase inhibitor, preparation method and use thereof in drug preparation |
| 02/14/2013 | WO2013020370A1 Pim kinase inhibitor and preparation method and use in medicinal manufacture thereof |
| 02/14/2013 | WO2013020368A1 Rhodiola rosea extracts and isolated compounds and uses thereof for treating neurodegenerative diseases |
| 02/14/2013 | WO2013020366A1 The use of ache as nuclease |
| 02/14/2013 | US20130041137 von Willebrand Factor (vWF) - Cleaving Protease |
| 02/14/2013 | US20130041009 Methods and means for increasing resistance to cell damage |
| 02/14/2013 | US20130041007 Selective Androgen Receptor Modulators |
| 02/14/2013 | US20130041000 Novel azole compound |
| 02/14/2013 | US20130040992 Substituted 2, 6-Diamino-3, 5-Dicyano-4-Aryl-Pyridines And Their Use As Adenosine-Receptor-Selective Ligands |
| 02/14/2013 | US20130040976 Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof |
| 02/14/2013 | US20130040001 Method of processing animal skin |
| 02/14/2013 | US20130039985 Method for aligning cells and applying homogenous strain throughout deformable engineered tissue constructs |
| 02/14/2013 | US20130039901 Treatment of Pompe's Disease |
| 02/14/2013 | US20130039900 Compositions and methods for altering cocaine esterase activity |
| 02/14/2013 | US20130039856 Products and Methods |
| 02/14/2013 | CA2844855A1 Pim kinase inhibitors and preparation methods and use in medicinal manufacture thereof |
| 02/14/2013 | CA2844852A1 Pim kinase inhibitors and preparation methods and use in medicinal manufacture thereof |
| 02/14/2013 | CA2844604A1 Pharmaceutical composition containing diamine derivative |
| 02/13/2013 | EP2557088A1 Physiologically active peptides |
| 02/13/2013 | EP2556835A1 Mixture, dissolving solution and pharmaceutical agent each comprising thermophilic microorganism |
| 02/13/2013 | EP2556834A1 The therapeutic use of tetrathiomolybdate |
| 02/13/2013 | EP2556828A1 Composition for amelioration of hypoalbuminemia |
| 02/13/2013 | EP2556058A1 Radioprotector compounds and methods |
| 02/13/2013 | EP2555765A1 Treatment of ataxia telangiectasia |
| 02/13/2013 | CN102933559A Optically active dibenzylamine derivative, and manufacturing method for same |
| 02/13/2013 | CN102933557A Radioprotector compounds and methods |
| 02/13/2013 | CN102933233A Agent for treating renal fibrosis |
| 02/13/2013 | CN102933223A Casein peptide for use in the treatment of uterine infections |
| 02/13/2013 | CN102920821A Medicinal composition for treating cattle heatstroke |
| 02/13/2013 | CN102920778A Mesona chinensis harvesting and primary processing method |
| 02/13/2013 | CN102920631A Elastic fibers forming accelerant |
| 02/13/2013 | CN102920033A Thermal and healthy sock with multilayer structure |
| 02/13/2013 | CN101721468B Method for preparing salvianolic acids |
| 02/13/2013 | CN101693742B Anti-IGF-I receptor antibody |
| 02/13/2013 | CN101624414B Nitrate medicament for inhibiting angiogenesis |
| 02/13/2013 | CN101495157B Disease treating method |
| 02/13/2013 | CN101357223B Preparation method of anti-stress agent for fishing |
| 02/13/2013 | CN101015353B Pure natural oxygenation health care beverage and compounding process thereof |
| 02/12/2013 | US8372981 Nitrogen-containing aromatic derivatives |
| 02/12/2013 | US8372968 RNA interference mediating small RNA molecules |
| 02/12/2013 | US8372449 Method for enhancing the DNA repair process, treating disorders associated with the DNA repair process, enhancing antitumor response and treating disorders associated with anti-tumor response in mammals by administering pruified quinic acid and/or carboxy alkyl ester |
| 02/12/2013 | US8372448 Method for enhancing the DNA repair process, treating disorders associated with the DNA repair process, enhancing antitumor response and treating disorders associated with anti-tumor response in mammals by administering purified quinic acid and/or carboxy alkyl ester |
| 02/12/2013 | US8372413 Mycobacterial disease, malaria, leishmaniasis, toxoplasmosis, schistosomiasis and clonorchiasis; antiallergens; asthma |
| 02/12/2013 | CA2596527C Igf-1r inhibitors |
| 02/12/2013 | CA2551119C Lipase inhibitor |
| 02/12/2013 | CA2480638C Substituted benzazoles and use thereof as raf kinase inhibitors |
| 02/12/2013 | CA2477350C Novel crystalline forms of the anti-cancer compound zd1839 |
| 02/12/2013 | CA2468892C Vitamin d analogues |
| 02/12/2013 | CA2445634C Acne treatment comprising lipoxygenase inhibitors |
| 02/12/2013 | CA2388450C Tadg-15: an extracellular serine protease overexpressed in carcinomas |
| 02/12/2013 | CA2382303C Methods of and compositions for inhibiting the proliferation of mammalian cells |
| 02/12/2013 | CA2336250C Anti-ccr2 antibodies and methods of use therefor |
| 02/07/2013 | WO2013020044A1 Treatment of fibrosis using microrna-19b |